Protein phosphorylation is a ubiquitous regulatory mechanism in eukaryotes and is essential for the control of gene expression.^[@ref1],[@ref2]^ Phosphorylation of RNA-binding proteins by protein kinases and their dephosphorylation by protein phosphatases is an important on/off switch to control RNA processing and mRNA decay in response to extracellular signals or cell cycle checkpoints.^[@ref3]^ Structural studies on phosphorylated and nonphosphorylated RNA binding proteins can provide important insights as to how an RNA binding protein executes the phosphorylation signal to control gene expression. The structural consequence of phosphorylating an RNA-binding protein, and the effect of phosphorylation on RNA--protein and protein--protein interactions in ribonucleoprotein complexes is just beginning to be understood.

Protein phosphorylation usually occurs in dynamic or disordered regions in RNA binding proteins and there are diverse mechanisms by which the phosphate moiety may participate in executing a structural response to the signal. The dianionic nature of a phosphoryl group (p*K*~a~ ∼ 6.9) at physiological pH, its tetrahedral geometry, presence of electron-rich oxygens, and its steric bulk allows it to participate in a network of hydrogen bonding interactions. A phosphate--arginine salt-bridge is the most common interaction observed. The arginine guanidinium group is unique in that it has a p*K*~a~ \> 12, a rigid planar structure, and a charge distribution that allows it to form a tight interaction with the doubly charged phosphate at physiological pH. Arginine--phosphate bonds have been proposed to have "covalent-like" stability.^[@ref4]^ Other residues involved in interaction with a phosphate are lysine, tyrosine, serine, threonine, asparagine, histidine, and metal ions. Phosphorylation may induce a global conformational change in a protein that may allosterically either promote or inhibit protein--protein or protein--RNA interactions. Silent phosphorylation effects can be observed where there is no conformational change induced in the RNA-binding protein, and the negative charge and steric bulk of the phosphate directly alters its association with an effector protein or RNA. Disorder-to-order or order-to-disorder transitions are most frequently reported, where the structural and dynamic changes are localized to the site of phosphorylation. In analogy to protein kinases, that have an "activation segment" that harbors a phosphorylated threonine or tyrosine residue that is required for kinase activation,^[@ref5]^ many RNA binding proteins have a "signal response segment" (SRS). The SRS usually comprises a disordered region of the protein that may become ordered upon phosphorylation. Structural studies on RNA binding proteins to date have shown that the structural consequences of phosphorylation tend to be localized in tertiary structure. Phosphorylation may organize the SRS to be a "hub" or epitope that serves as a recognition site for another protein in the ribonucleoprotein complex.

In this review, I describe the structural outcome to phosphorylation observed in RNA binding proteins where such information is available for intact phosphorylated and nonphosphorylated proteins, or their subdomains, from X-ray crystallography or NMR spectroscopy. In particular, RNA binding proteins that play a role in splicing and mRNA decay have been highlighted.

Structural Control of Alternative Splicing by Phosphorylation {#sec1.1}
=============================================================

The functional consequences of reversible phosphorylation in regulating alternative splicing and splice-site recognition are well established.^[@ref6]^ Proteomics studies have identified \>300 proteins as being associated with splicing complexes, and many of these factors are either phosphorylated or glycosylated.^[@ref7]^ A rapid change in alternative splice site selection has been observed in response to cellular stimuli that correlates well with a change in the phosphorylation state of splicing factors.^[@ref8]−[@ref10]^ The effects of phosphorylation can be mediated either by remodeling ribonucleoprotein complexes (mRNPs) via altering protein--protein or protein--RNA interactions^[@ref11]−[@ref13]^ or by changing the subcellular localization of the splicing factor.^[@ref14],[@ref15]^ Phosphorylation of splicing regulatory proteins or SR proteins can occur in arginine and serine rich (RS) domains that are between 50 and 300 residues. These RS domains can be hypophosphorylated at 8--10 residues or hyperphosphorylated by multiple kinases at \>20 serine residues.^[@ref16]^ Phosphorylation of SR proteins can alter subcellular localization and macromolecular interactions in spliceosomes and hence affect splice site selection. Several diseases^[@ref17]−[@ref19]^ show variation in splicing activity due to either altered kinase activity or a change the phosphorylation state of splicing factors. Therefore, understanding the molecular basis as to how phosphorylation affects the structure of splicing factors in the context of larger spliceosomal assemblies may be a useful strategy for drug development.

RS Domains In SR Splicing Factor 1 (SFRS1) {#sec1.2}
==========================================

The SR protein SFRS1 (previously known as Alternative Splicing Factor (ASF)/Splicing Factor 2 (SF2))^[@ref20]^ is the best-studied member of the SR protein family. SFRS1 has two RNA recognition motifs (RRMs) in the N-terminus and the RS domain in the C-terminus with 20 serines (Figure [1](#fig1){ref-type="fig"}A, B). SFRS1 is phosphorylated on 12 of these serines in the N-terminal portion of the RS domain (RS1) (Figure [1](#fig1){ref-type="fig"}B) by the kinase SR protein kinase-1 (SRPK1).^[@ref21],[@ref22]^ Hyperphosphorylation of RS1 in the cytoplasm by SRPK1 and cdc2-like (Clk/Sty) kinases facilitates dissociation of SFRS1 from mRNP complexes, promoting its re-entry into the nucleus^[@ref13]^ by associating with the nuclear import factor Transportin 3 (or Transportin-SR2).^[@ref23]^ Once in the nucleus, phosphorylated SFRS1 associates with U1--70K and U2AF proteins during spliceosome assembly.^[@ref24],[@ref25]^ SFRS1 may also undergo additional phosphorylation by the cdc2-like (Clk/Sty) kinases in the nucleus resulting in its dissociation from speckles.^[@ref26]^

![Crystal structures of phosphorylated SFRS1 bound to Transporting 3 and SRPK1. (A) Domain structure of SFRS1 is depicted. (B) The sequence of the RS domain consisting of the N-terminal RS1, which is phosphorylated by SRPK1, is shown. The C-terminal RS2 region is phosphorylated by Clk/Sty kinases. (C) The 2.9 Å crystal structure of the SRPK1- SFRS1 complex (PDB code 3BEG) is shown. The kinase is in blue ribbon and SFRS1 in red. (D) Specific interactions between protein side chains of SRPK1 and the RS1 domain of SFRS1 in the docking site are depicted. (E) Cartoon representation of the 2.6 Å crystal structure of Transportin 3 (in blue) bound to the SFRS1 RRM2-RS1 region (in red) (PDB code 4C0O). Heat repeats 12--16 (shown in green) primarily interact with RS1 (in gold). (F) The specific interactions between protein side chains of Transportin 3 and the RS1 domain of SFRS1 is depicted. An extensive arginine-zipper-like interface is observed. The Transportin 3 helices are in gray and the RS1 domain in magenta. Arginines (R206, R208, and R210) from SFRS1 are shown in magenta/blue stick, the phosphoserines (S209 and S207) are in orange. Residues from Transportin 3 that interact with the RS1 peptide are in green stick. Black dashes denote salt bridge interactions between arginines from Transportin 3 and red dashes denote salt bridge interactions between arginines from SFRS1.](cb-2014-00860x_0005){#fig1}

The SFRS1 RS domain is unstructured in the absence of bound targets by circular dichroism (CD)^[@ref27]^ and NMR.^[@ref28]^ In contrast to experimental evidence from CD and NMR that support the unstructured state of the RS domain, molecular dynamics (MD) simulations previously suggested that the unphosphorylated RS domain adopts a α-helical structure.^[@ref30],[@ref31]^ Upon phosphorylation, the RS domain was predicted to undergo a conformational change to form either an extended structure or an "arginine claw".^[@ref30],[@ref31]^ A recent quantitative NMR and MD study^[@ref28]^ shows unequivocally that the unphosphorylated RS domain is highly disordered, and it switches to a compact, partly ordered arched shape upon phosphorylation. NMR spin relaxation measurements show small (\<0.1) ^15^N--^1^H heteronuclear nuclear Overhauser effects (hetNOEs), an indicator of fast motions in the pico-to-nanosecond time scale. The hetNOE values coupled with large NMR line-widths suggest that the unphosphorylated RS1 experiences both fast and slow motions in the micro-to-millisecond time scale. Upon phosphorylation, the hetNOE values increase to 0.6 ± 0.1 and the vicinal three-bond couplings, which are correlated to the backbone dihedral angles, indicate the presence of helical or turn-like structure. A structural ensemble was calculated based on NMR data that includes heteronuclear chemical shifts, one-bond and three-bond scalar couplings, and residual dipolar couplings that were combined with MD simulations for the unphosphorylated RS1, and the monoionic (PO~4~^--^) and dianionic (PO~4~^2--^) protonation states of the phosphoserines. The ensemble provides no evidence for an "arginine claw", but the RS1 domain is partly ordered assuming an arch-like structure upon phosphorylation, with the arginine and phosphoserine side-chains adopting preferred rotamer conformations. This decrease in conformational entropy upon phosphorylation of the RS domain may promote association of SFRS1 with a wide range of protein targets. Therefore, RS domains are an example where the signal response segment of the RNA binding protein undergoes a disorder to partly ordered state upon state upon hypo- or hyperphosphorylation.

The mechanism by which the RS domain of SFRS1 is hypophosphorylated in a sequential and processive manner from the C- to the N-terminal end of RS1 is unique and has been well studied by X-ray crystallography and kinetic measurements.^[@ref33]−[@ref36]^*In vitro*, SRPK1 binds SFRS1 with high affinity, with a *K*~d~ between 50 and 100 nM and can stay bound to the RS substrate for eight cycles of phosphorylation before releasing the substrate. SR protein kinases have unusual specificity in that they only phosphorylate serines but not threonines that lie adjacent to arginines.

The 2.9 Å crystal structure of the SRPK1--SFRS1 complex (PDB code 3BEG) illustrates the mechanism of hypophosphorylation of RS1^[@ref37]^ (Figure [1](#fig1){ref-type="fig"}C). There are three regions on SFRS1 that make extensive contacts with SRPK1. First, the second RRM (RRM2) contacts both lobes of the kinase domain via three loops (the α1/β1 loop, the β2/β3 loop, and the βN/β4 loop) burying 1079 Å^2^ of accessible surface area between RRM2 and the kinase domain. Intriguingly the mode of recognition of SRPK1 by SFRS1 via α-helix-1 is very similar to how RRM2 recognizes RNA.^[@ref38]^ The SFRS1 RRM2 (also called a pseudo-RRM) has a canonical α/β fold observed in most RRM domains; however, β4 is longer, and it has an additional β-strand (βN) to form a five-stranded β--sheet, which extends the interaction surface with the kinase. Solution NMR studies^[@ref38],[@ref39]^ show that the region corresponding to the βN/β4 hairpin observed in the crystal is highly mobile, and in solution, the shorter β4-strand is followed by a break in the strand and a β3′-β3″ hairpin. From the kinase perspective, the glycine-rich loop, the α-helices D and F, and the nucleotide-binding pocket make contacts with RRM2. The interactions with the glycine-rich loop appear to orient the nucleotide for phosphoryl transfer and catalysis. This structure, along with the structure of RRM2/RS1 bound to Transportin 3, demonstrate the pivotal role played by RRM2 in facilitating protein--protein interactions mediated by RS domains by acting as an accessory domain for high-affinity binding. RRM2 also binds RNA using the same surface in α-helix-1,^[@ref38]^ indicating it plays an essential role in regulating both protein--protein and protein--RNA interactions.

Second, the N-terminal portion of RS1 sits in a docking groove in the kinase domain (Figure [1](#fig1){ref-type="fig"}D). The interaction between the RS region and the kinase are electrostatic. Alternate arginines on the RS domain form salt-bridge interactions with acidic residues in the docking site. The network of electrostatic interactions likely facilitates movement of the substrate RS from the docking site to the catalytic site without energetic penalty. Only a portion of the RS1 peptide was observed in the crystal structure. No electron density is observed for the linker connecting the RRM2 to residue 201 of the RS1 domain, indicating the RS1 remains flexible when bound to the kinase.

Finally, the C-terminal phosphoserine in RS1 contacts a highly basic region near the P+1 loop of the kinase by interacting with Arg515, Arg518, and Arg561 of SRPK1. The structure explains how SRPK1 binds SFRS1 with high affinity and how it phosphorylates processively in a directional manner from the C- to the N-terminus. The C-terminal end of the RS1 domain sits in the active site and RS1 is threaded through the basic groove until it dissociates from the kinase. Dissociation is facilitated by unfolding of the RRM2 β4 strand when the last serine approaches the active site.

A 2.6 Å crystal structure (PDB code 4C0O) of Transportin-3 complexed to the phosphorylated RRM2-RS1 domain of SFRS1 (Figure [1](#fig1){ref-type="fig"}E) reveals an extensive arginine-zipper-like interaction between two serine phosphates (out of three phosphoserines in the crystallized molecule) and arginine residues in HEAT repeats 14--17 of Transportin 3.^[@ref32]^ The arginines of the RS domain in turn form salt bridges with Asp and Glu residues in Transportin 3 (Figure [1](#fig1){ref-type="fig"}F). Most of the interactions are electrostatic, with 11 salt-bridges in the complex between an extended phosphorylated RS domain and the inner face of Transportin 3. Phospho-Ser207 of the RS domain interacts with the guanidinium groups of Arg620, Arg661, Arg664, and Arg667 of Transportin 3, and phospho-Ser209 of the RS domain interacts with the guanidinium groups of Arg667, Arg671, Arg754, and Arg758 of Transportin 3. The RRM2 domain is also involved in protein--protein contacts and is sequestered in the inner concave face of Transportin 3 between HEAT repeats 4--7 and 19--20. The total interface between the cargo (RRM2-RS1 domain of SFRS1) and Transportin 3 is ∼4300 Å^2^. Hypophosphorylation of RS1 is essential for the interaction between SFRS1 and Transportin 3, and is required for its import into the nucleus *in vivo*.^[@ref23]^

How does hypo- or hyperphosphorylation of the SFRS1 RS domain affect its interactions with RNA and U1--70K during spliceosome assembly? Cho *et al*.^[@ref40]^ examined the interaction of RRMs 1 and 2 in the SFRS1 N-terminus with a 13 nt exonic splicing enhancer (ESE) sequence present in the receptor tyrosine kinase (*Ron*) mRNA in the presence and absence of unphosphorylated, hypophosphorylated (p-SFRS1), or hyperphosphorylated (pp-SFRS1) RS1 domains using filter binding experiments as well as EMSA. The hypophosphorylated RS1 domain was phosphorylated at 8--10 serines whereas the hyperphosphorylated RS1 domain was phosphorylated at 20--22 serines in RS1 as confirmed by mass spectrometry.^[@ref41]^ Unphosphorylated SFRS1 bound the *Ron* ESE in a specific manner, with a *K*~d~ of 172 ± 34 nM by filter binding and 50 ± 5 nM by EMSA. p-SFRS1 bound the *Ron* ESE with affinity comparable to the unphosphorylated SFRS1 protein (*K*~d~ of 180 ± 38 nM by filter binding and 26 ± 11 nM by EMSA). Hyperphosphorylation of SFRS1 at 20--22 serines in its RS domain weakened affinity for the RNA by ∼10-fold (*K*~d~ of 540 ± 16 nM by filter binding). Furthermore, the unphosphorylated RS1 domain was found to interact directly with RRMs 1--2 of SFRS1, thereby stabilizing the SFRS1--RNA complex. In contrast, hyperphosphorylated RS1 did not interact with RRMs 1--2 of SFRS1 but did promote interaction of SFRS1 with U1--70K. Therefore, the main role of RS1 hyperphosphorylation appears to be to promote protein--protein interactions with U1--70K during spliceosome assembly. Only a small decrease in affinity (of ∼10-fold) of pp-SFRS1 toward *Ron* ESE mRNA is observed.^[@ref40]^

These biochemical, structural, and dynamics studies (summarized in Table [1](#tbl1){ref-type="other"}) reveal that the RS domain acts as a phosphorylation-dependent switch during spliceosome assembly. RS domains usually undergo two transitions in their phospho-dependent interactions with other proteins. The highly disordered unphosphorylated RS state interacts nonspecifically with its RRMs to stabilize the SFRS1--RNA complex by ∼5--10 fold.^[@ref40]^ Upon hyperphosphorylation, the RS1 domain dissociates from its RRMs and likely forms a more compact structure, which is "primed" to form a "fuzzy"^[@ref42]^ extended charged platform that docks into the binding partner via a network of electrostatic interactions. Hyperphosphorylation of RS1 weakens affinity of SFRS1 for the RNA by ∼10 fold.^[@ref40]^ The RS1 domain also appears to require the neighboring RRM to modulate its affinity toward protein targets by extending the buried surface area between SFRS1 and its interacting partner. Therefore, phosphorylation of RS domains modulates protein--protein and protein--RNA interactions of SFRS1 during splicing by undergoing a disorder-to-order transition that is coupled to protein (such as U1--70K or Transportin 3) binding.

SPSP motif in Splicing Factor 1 (SF1) {#sec1.3}
=====================================

Insights into the role of phosphorylation in regulating alternative splicing have also come from structural studies of phosphorylated and nonphosphorylated splicing factor 1 (SF1).^[@ref43],[@ref44]^ SF1 participates in the assembly of complex E of the spliceosome^[@ref45]^ and is important for 3′-splice site recognition by binding to the branch point sequence (BPS) of the RNA.^[@ref46]^ SF1 also interacts with the essential U2 snRNP auxiliary factor large subunit (U2AF^65^) that in turn binds the poly pyrimidine tract located at the 3′ splice site.^[@ref47],[@ref48]^

The SF1 protein consists of five structural domains (Figure [2](#fig2){ref-type="fig"}A): (1) N-terminal U2AF ligand motif (ULM) that binds the U2AF^65^ homology motif (UHM), (2) a helix hairpin (HH) motif containing the phosphorylated SPSP containing domain, (3) the K homology (KH) and Quaking homology 2 (QUA2) KH-QUA2 domain that binds RNA, (4) a zinc knuckle motif that binds RNA nonspecifically, and (5) a proline rich region at the C-terminus that may interact with SH2 containing proteins in signaling pathways. U2AF^65^ has RS and ULM domains at the N-terminus followed by RRM1, RRM2 that bind RNA, and the UHM domain that mediates protein--protein interactions with SF1 (Figure [2](#fig2){ref-type="fig"}A). Structures of the SF1 KH-QUA2 domain bound to BPS RNA^[@ref49]^ and the U2AF^65^ RRM1-RRM2 domains bound to the poly-pyrimidine tract RNA^[@ref50],[@ref51]^ have revealed how these proteins contact the RNA at the 3′-splice site. The structure of the UHM domain of U2AF^65^ complexed to the ULM domain of SF1 shows how protein--protein interactions occur via the ULM motif.^[@ref52]^

![X-ray crystallographic and NMR structures of phosphorylated SF1. (A) Schematic showing the domain organization and interactions between SF1, U2AF, and the RNA. (B) Solution NMR structural ensemble (PDB code 2M09) of the free helix hairpin (HH) motif consisting of two α-helices in an antiparallel arrangement connected by a flexible linker is shown. The serines that are phosphorylated are in magenta in a dynamic SPSP loop. (C) The 2.29 Å crystal structure of phosphorylated SF1 HH bound to the U2AF UHM (PDB code 4FXW) is shown. SF1 is in red, and U2AF in blue. The phosphorylated serines are depicted in magenta. (D) Interactions of the phosphates with neighboring arginines to form an "arginine claw" are shown.](cb-2014-00860x_0006){#fig2}

SF1 is constitutively phosphorylated at two conserved serines in the SPSP motif (Ser80--Pro81--Ser82--Pro83) in HEK cells,^[@ref53]^ and serine phosphorylation may be important for cancer progression.^[@ref54],[@ref55]^ Phosphorylation of SF1 at Ser80 and Ser82 by KIS kinase^[@ref56]^ has been suggested to be important for the stability of the SF1--U2AF^65^--RNA ternary complex.^[@ref53],[@ref57]^ It is also required for cell proliferation in NIH 3T3 cells, and contributes to the SF1-U2AF^65^ interaction *in vivo*.^[@ref44]^ Intriguingly, this SPSP motif lies between the KH-QUA2 domain and the ULM that binds the UHM of U2AF^65^ (Figure [2](#fig2){ref-type="fig"}A). How does phosphorylation at the SPSP sequence that lies between the ULM and the KH-QUA2 motifs of SF1, affect its interaction with RNA or U2AF^65^? Solution NMR and X-ray crystallographic studies from the Kielkopf^[@ref44]^ and Sattler^[@ref43]^ laboratories have revealed the structural and dynamic changes that occur in the binary SF1--U2AF^65^ complex in response to phosphorylation at the SPSP motif, providing new insight into how phosphorylation may promote assembly of complex E of the spliceosome.

Zhang *et al*.^[@ref43]^ determined the solution NMR structure of the helix hairpin (HH) motif (residues 27--145) of SF1 and the entire SF1 N-terminus (residues 1--145) consisting of the ULM and HH domains bound to U2AF^65^. The HH region consists of two α-helices in an antiparallel arrangement connected by a flexible linker (PDB code 2M09) that has the site of SPSP phosphorylation (Figure [2](#fig2){ref-type="fig"}B). The helices are stabilized by hydrophobic contacts between aliphatic Leu, Ile, and Met residues that interdigitate to form a hydrophobic core. The helix hairpin structure is further stabilized by the C-terminal extension that folds back and packs against helix α2 of the hairpin fold. The SPSP motif is solvent exposed in a flexible linker between the two helices (Figure [2](#fig2){ref-type="fig"}B). The solution NMR structure of the unphosphorylated SF1^ULM+HH^ −U2AF^65-UHM^ complex shows a burial of an additional ∼500 Å^2^ of a hydrophobic interface between the two proteins due to the HH domain. This interaction therefore forms a secondary binding interface between SF1-U2AF^65^ proteins, extending the interaction interface by ∼500 Å^2^. NMR ^15^N-relaxation measurements demonstrate that the SRS "linker" region, which comprises the site of phosphorylation, becomes rigid via interaction of the phosphates with the guanidinium groups of Arg93, Arg97, and Arg100.^[@ref43]^ These solution NMR studies indicate that the effects of phosphorylation are localized to the SPSP loop and do not drastically affect the overall structure or dynamics of the SF1^ULM+HH^ −U2AF^65-UHM^ complex.

How does phosphorylation of the SPSP motif of SF1 affect binding affinity toward U2AF^65^? The unphosphorylated helix hairpin motif only slightly increases the affinity of SF1 for the U2AF^65-UHM^ by isothermal titration calorimetry (ITC), when measured as isolated domains. The *K*~d~ for the interaction of the SF1^ULM^ and U2AF^65-UHM^ is reported to be 127 ± 48 nM and that of SF1^ULM+HH^ and U2AF^65-UHM^ is reported to be 84 ± 24 nM.^[@ref43]^ Phosphorylation of the SPSP motif did not alter the *K*~d~ for the interaction of the SF1^ULM+HH^ and U2AF^65-UHM^ by ITC. In contrast to the ITC measurements performed by Zhang *et al*.^[@ref43]^ on the individual domains, GST pull-down experiments performed by Wang *et al*.^[@ref44]^ on almost full-length proteins shows that the SASA double mutant is less efficient than the phosphorylated protein in its interaction with U2AF^65^, and phosphorylation of SF1 at the SPSP motif contributes to interaction with U2AF^65^. The small increase in binding observed in GST pull-down experiments upon phosphorylation in the Wang *et al*.^[@ref44]^ study could be due to inclusion of the SF1 KH-QUA2 domain, a difference in methodology, or buffers used. Although both studies show that phosphorylation of the SPSP motif is not necessary for the interaction of SF1 and U2AF^65^*in vitro*, the apparently small but significant effects of phosphorylation on binding of full-length proteins *in vitro* and *in vivo* in the presence of RNA should be investigated in greater detail. The mechanism by which phosphorylation may affect the affinity, albeit to a small extent, between full-length SF1 and U2AF^65^ is not fully resolved.

In general, there is agreement between the solution NMR studies of Zhang *et al*.^[@ref43]^ and the X-ray crystallographic studies of Wang *et al*.,^[@ref44]^ in that the effects of phosphorylation on the SF-U2AF^65^ complex are localized to the SRS and similar hydrophobic interfaces are observed between unphosphorylated SF1 and U2AF^65^ in the NMR and crystal structures. Calorimetric studies performed by Wang *et al*.^[@ref44]^ on nearly full length SF1 (residues 1--255; comprising the ULM, HH/SPSP, and KH-QUA2 domains) and the U2AF^65-UHM^ indicate that there is a large change in the difference in heat capacity (Δ*C*~p~) that corresponds to burial of an additional ∼1900 Å^2^ of surface area in the unphosphorylated SF1-U2AF heterodimer. The 2.29 Å crystal structure of phosphorylated SF1 (residues 14--132)-U2AF^65-UHM^ (PDB code 4FXW) confirms that ∼1400 Å^2^ of hydrophobic surface area is buried in the complex due to the presence of the HH/SPSP domain, corroborating their calorimetry studies (Figure [2](#fig2){ref-type="fig"}C). Phosphorylation at the SPSP motif induces an "arginine claw" in the crystal structure (Figure [2](#fig2){ref-type="fig"}D). Three arginines of the HH/SPSP domain of SF1 (Arg93, Arg97, and Arg100) form strong intramolecular interactions with the SF1 phosphoserines so as to stabilize the loop conformation. The side chains of Lys104 and Arg79 are also in proximity to the phosphates, thereby providing a favorable positively charged electrostatic environment to surround the phosphoryl groups. In contrast, the 2.48 Å structure of the unphosphorylated SF1 domain bound to U2AF^65-UHM^ shows little electron density for loop residues 74--81 indicating structural disorder for these residues. The structural data is also corroborated by thermostability measurements that show significant stabilization of the phosphorylated SF1 (residues 14--132)--U2AF^65-UHM^ complex compared to the unphosphorylated complex. The backbone C^α^ atoms of SF1 HH domain (residues 46--66/97--115; without the loop) have an rmsd of 0.50--0.68 Å between the phosphorylated and nonphosphorylated structures, indicating that with the exception of the SPSP loop, the HH domain structure is similar in the two phosphorylated and nonphosphorylated structures, consistent with NMR studies.

An important question that remains unanswered is how phosphorylation at the SPSP motif affects spliceosome assembly by the two proteins? Are there global changes observed in the RNA bound functionally relevant ternary complexes? A comparison of the pairwise distribution functions of the nonphosphorylated and phosphorylated SF1^ULM+HH^ −U2AF^65-UHM^ complexes by low-resolution small-angle X-ray scattering (SAXS) shows only minor differences in the derived radii of gyration for these complexes in both studies.^[@ref43],[@ref44]^ Whereas the addition of RNA does induce a large change in the radii of gyration (*R*~g~) of both phosphorylated and nonphosphorylated complexes by SAXS (δ*R*~g~ of 0.52 nm corresponding to D~max~ of 3 nm), phosphorylation at the SPSP motif has a smaller effect on *R*~g~ values (δ*R*~g~ of 0.06 nm, no significant difference in D~max~).^[@ref43]^ When the effect of phosphorylation at the SPSP motif on RNA binding was tested using electrophoretic mobility shift assays (EMSA), a small but significant change was noted in that the phosphorylated protein complex bound RNA with slightly higher efficiency,^[@ref43]^ as previously reported.^[@ref53]^ Both the SAXS and EMSA studies indicate that the effects of phosphorylation on RNA association are likely to be minor. Future high-resolution structures on the ternary nonphosphorylated and phosphorylated SF1^ULM+HH^ −U2AF^65-UHM^--RNA bound complexes should reveal the precise role of phosphorylation in the assembly of the E complex of the spliceosome.

These studies by NMR spectroscopy, X-ray crystallography, and SAXS, combined with biochemical and biophysical data on phosphorylated and nonphosphorylated SF1, both free and complexed to U2AF^65^ have provided detailed insight into the structural effects of SF1 phosphorylation (see Table [1](#tbl1){ref-type="other"} for a summary of structural and biochemical data). The data indicate that phosphorylation of the SPSP motif in SF1 results in localized changes in dynamics surrounding the site of phosphorylation. Phosphorylation of SF1 does not appear to have a large effect on RNA binding for either SF1 or U2AF^65^ in the RNA bound ternary complex. Surprisingly, phosphorylation also does not affect the affinity or structure of the SF1-U2AF^65^ binary complex. How does SPSP phosphorylation affect spliceosome assembly? The structural studies suggest that SPSP phosphorylation of SF1 is required to structure the loop so as to "signal" the recruitment of a third protein in complex E of the spliceosome. Future studies should test this hypothesis.

###### Summary of Structural and Biochemical Data on Phosphorylated RNA Binding Proteins

  RNA-binding protein (PDB codes available)                                                                                                                                                            structure determination method                                                   phosphorylated site/s                                              mechanism                                                                      kinase                                                      change in *K*~d~ toward RNA due to phosphorylation                                                                                         change in *K*~d~ toward protein target due to phosphorylation
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ------------------------------------------------------------------ ------------------------------------------------------------------------------ ----------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **SFRS1**                                                                                                                                                                                            NMR (1), MD (1), X-ray (2)                                                       ∼8--10 serines in RS1 by SRPK1; 20 serines by both SRPK1 and Clk   localized disorder to partial order transition upon phosphorylation            SRPK1 Clk/Sty                                               5--10 fold decrease in Ron ESE mRNA affinity due to hyperphosphorylation at 20 sites by EMSA and filter binding^[@ref40]^                  not determined quantitatively
  \(1\) RS1 domain only (no PDB code available)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  interaction of SFRS1 with Transportin 3 is salt dependent with significant reduction in binding in 500 mM NaCl in GST pull-down experiments consistent with an electrostatic interaction^[@ref32]^                                                                                                                                                                                                                                                                                                                                                                                                                                             
  \(2\) RRM2-RS domain (3BEG bound to SRPK1; 4C0O bound to Transportin 3)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  localized disorder to order transition upon SRPK1 and Transportin 3 binding                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  **SF1**                                                                                                                                                                                              X-ray and NMR                                                                    Ser80, Ser82                                                       localized disorder to order transition upon phosphorylation                    KIS kinase                                                  not quantified; small increase in efficiency of RNA binding by SAXS and EMSA.^[@ref43],[@ref44]^                                           Small increase (\<2-fold) in association by ITC^[@ref43]^
  2M09 (free HH- NMR)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  2M0G (unphosphorylated SF1 NYD bound to U2AF UHM -- NMR)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  *K*~d~ values: pSF1 + U2AF65^RRM123^ = 96 ± 32 nM; SF1 + U2AF65^RRM123^ = 114 ± 23 nM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  4FXW                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  (phosphorylated SF1 NTD bound to the U2AF UHM -- X-ray) 4FXX (unphosphorylated SF1 NTD (residues 26--132))                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  **SLBPL-motif**                                                                                                                                                                                      X-ray                                                                            Thr171(hSLBP)/ Thr230 (dSLBP)                                      localized disorder to order transition upon phosphorylation                    unknown                                                     7--11 fold increase in affinity toward histone mRNA stem-loop^[@ref75],[@ref76]^                                                           \>32-fold toward Pin1 using fluorescence anisotropy^[@ref80]^
  unknown possibly CK2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  unknown                                                                                                                                                                                              ∼27 fold increase in affinity toward histone mRNA stem-loop by dSLBP^[@ref75]^                                                                                                                                                                                                                                                                                                                                                            
  4QOZ (T171 phos) 4L8R (T171 nonphos)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Ser221, Ser222, and Thr226 (hSLBP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Ser269, Ser271, Ser273, Ser275 (dSLBP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  **KSRP KH1**                                                                                                                                                                                         NMR, X-ray                                                                       Ser193                                                             order to disorder, i.e., global unfolding of KH1 domain                        AKT                                                         no detectable difference by EMSA and ITC^[@ref89]^                                                                                         \>1000-fold increase in affinity toward 14--3--3ζ upon phosphorylation by ITC^[@ref89]^
  2OPU (nonphos KH domain) 1QJB (phospho-Ser peptide bound to 14--3--3ζ)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  **Upf1**/SMG proteins                                                                                                                                                                                X-ray                                                                            Thr28, Ser1078, Ser1096, and Ser1116 in SQ motifs in Upf1          localized disorder to order transition upon phosphorylation                    SMG-1; possibly other SQ kinases such as ATR, ATM, DNA-PK   unknown                                                                                                                                    \>100-fold increase in affinity toward SMG7 upon phosphorylation by ITC^[@ref105]^ Binding to SMG5--SMG7, SMG6, and SMG7 is phosphorylation dependent in GST-pull down and coimmunoprecipitation experiments^[@ref103],[@ref104]^
  1YA0 (N-terminal domain of SMG7)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  4UM2 (TPR domain of SMG6)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  3ZHE (*C. elegans*SMG5--SMG7)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  **TiaS**                                                                                                                                                                                             X-ray                                                                            Thr18                                                              silent phosphorylation                                                         unknown                                                     no significant difference toward tRNA is predicted^[@ref111],[@ref112]^                                                                    N/A
  (phosphorylated)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  3AMT 3AMU 3AU7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  **Ire1**                                                                                                                                                                                             X-ray                                                                            Ser724 in activation segment (in human Ire1)                       global conformational change involving dimerization and domain reorientation   Ire1 autophosphorylation                                    3--5 fold decrease in *K*~m~ for the RNA substrate due to phosphorylation at 1--4 sites; 2--40 fold effect on *K*~cat~/*K*~m~^[@ref118]^   N/A
  3P23 2RIO/3LJ0 3FBV                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

Phosphorylation-Dependent Control of mRNA Decay {#sec1.4}
===============================================

It has long been known that mRNA decay rates can change dramatically in the presence of extracellular stimuli such as hormones, stress, viral infections, cytokines, etc. Several RNA binding proteins such as proteins that bind AU-rich elements (AREs) are directly under the control of signaling pathways^[@ref58],[@ref59]^ and play central roles in regulating the immune response and human diseases. We are only beginning to understand how kinase activated pathways regulate the phosphorylation state of RNA-binding proteins and mRNA decay factors downstream.^[@ref3]^ In this section, I discuss three decay factors that are regulated by phosphorylation: SLBP, KSRP, and Upf1.

The L-Motif of Stem-Loop Binding Protein (SLBP) {#sec1.5}
===============================================

Histone proteins are required for packaging DNA into chromatin as well as for epigenetic regulation via the histone code.^[@ref60],[@ref61]^ In mammals, five major classes of the canonical histone proteins (H1, H2A, H2B, H3, and H4) are encoded by ∼65 genes, their biogenesis being tightly coupled to DNA replication.^[@ref62]^ These replication-dependent histone mRNAs are cell cycle regulated, and their expression is coordinated with DNA replication during the "synthesis-phase" or S-phase of the cell cycle.^[@ref63]^ The major cis-element responsible for cell cycle regulation of the histone mRNAs is a highly conserved 16-nucleotide stem-loop present in the unique 3′ untranslated region (3′ UTR) of histone mRNAs that binds Stem Loop Binding Protein (SLBP).^[@ref64],[@ref65]^ The hairpin sequence includes a six base pair stem that is capped by a UYUM tetraloop. SLBP^[@ref66]^ and CstF64^[@ref200]^ are the only two cell cycle regulated trans-acting factors whose expression during S-phase is correlated to expression of histone mRNAs. SLBP is an architectural protein that is important for efficient pre-mRNA processing of histone mRNAs,^[@ref67],[@ref68]^ histone mRNA export,^[@ref69]^ translation,^[@ref70]^ and degradation^[@ref71]^ of these mRNAs by its ability to interact with the RNA as well as a plethora of proteins in ribonucleoprotein complexes.

All SLBP proteins form a highly stable complex with histone stem-loop RNA.^[@ref72],[@ref73]^ An apparent equilibrium dissociation constant (*K*~d~) of between 1.5 nM-47.5 nM has been measured for the interaction of human, *Drosophila*, and *Xenopus* SLBP RNA Binding Domains (RBDs) with the stem-loop by several laboratories.^[@ref72],[@ref74]−[@ref76]^ The off-rate for dissociation of the complex is very slow (*k*~off~ = 5.4 × 10^--4^ min^--1^; *t*~1/2~ ∼ 21.4 h)^[@ref75]^ indicating that once formed, the SLBP--RNA complex functions as an integral unit. The minimal protein sequence required for specific and high affinity RNA binding is a ∼73 residue segment that bears no sequence homology to any other protein in the eukaryotic genome^[@ref75]^ (Figure [3](#fig3){ref-type="fig"}A). In the absence of RNA, the SLBP RBD is intrinsically disordered in solution^[@ref73],[@ref75]^ and folds in the presence of RNA.^[@ref73]^ The crystal structure of human SLBP in a ternary complex with the histone mRNA stem-loop and the exonuclease ERI-1/3′hExo (PDB codes 4L8R and 4QOZ)^[@ref77]^ reveals that the SLBP RBD forms a characteristic inverted L-shaped structure consisting of three α-helices that are connected by loops. Helix-2 lies orthogonal to helices 1 and 3 forming a novel RNA binding fold called the SLBP L-motif (Figure [3](#fig3){ref-type="fig"}B). Recognition of the RNA stem-loop occurs by the outer face of the SLBP L-motif by unfolding the tetraloop of the RNA.^[@ref74],[@ref78]^ SLBP is anchored by sequence specific side-chain-to-base contacts between the guanidinium group of an arginine (Arg181) to the O6 of the first and second guanines, G6 and G7, in G-C base pairs at the bottom of the RNA helix, and a third hydrogen-bond to the G6 phosphate at the base of the stem.

![X-ray crystal structure of phosphorylated human SLBP. (A) Schematic showing the domain organization of human SLBP (hSLBP) and *Drosophila* SLBP (dSLBP). The RNA binding domain is designated the "L-motif" and is followed by an acidic region, rich in Asp and Glu residues, that is also phosphorylated. The N-terminal domain is involved in translation activation (TAD). Phosphorylation sites that have been mapped *in vivo*([@ref76],[@ref80],[@ref124]) are indicated. (B) The T171 phosphorylated SLBP L-motif is shown with a characteristic L-shape as seen in the crystal structure of the hSLBP/histone mRNA/3′hExo ternary complex (PDB code 4QOZ). The fold consists of three α-helices connected by a 20-residue flexible loop that has the site of phosphorylation (shown in stick). Hydrophobic residues at the junction of the helices are shown in yellow (inset). (C) Hydrogen bonding interactions mediated by the phosphothreonine with R163, R169, K146, Y151, and W190 (via a water molecule) are shown. The structured loop that is disordered in the unphosphorylated SLBP structure is fully ordered in phosphorylated SLBP. The unphosphorylated structure is shown in blue and the phosphorylated structure in red ribbon. (D) Residues in helix-2 and the structured loop that undergo a conformational change upon SLBP phosphorylation and have been implicated in RNA processing are highlighted.](cb-2014-00860x_0001){#fig3}

A unique feature of SLBP proteins is that they are constitutively phosphorylated at an invariant threonine (Thr171 in hSLBP and Thr230 in dSLBP) *in vivo*([@ref76]) (Figure [3](#fig3){ref-type="fig"}A). Phosphorylation of SLBP at Thr230 is essential for nuclear localization of dSLBP, is essential for viability of *Drosophila* embryos and for histone pre-mRNA processing in flies *in vivo*.^[@ref79]^ In mammalian HEK293 cells, the T171A mutant SLBP is more cytoplasmic and is present in significant number of non-S-phase cells.^[@ref80]^ In contrast, the T171D and T171E phosphomimic mutants are almost exclusively nuclear throughout the cell cycle.^[@ref80]^ Therefore, phosphorylation at Thr171 is required for efficient import into the nucleus and proper cell cycle regulation of SLBP.^[@ref80]^ Phosphorylation at Thr171 (in a TPNK sequence) also makes SLBP a substrate for the prolyl isomerase Pin1.^[@ref80]^ The SLBP L-motif undergoes *cis--trans* proline isomerization in solution.^[@ref75]^ Pin1 acts with protein phosphatase PP2A to dephosphorylate SLBP at the end of S-phase, dissociating SLBP from the histone mRNA, thereby facilitating mRNA decay.^[@ref80]^ Pin1 knockdown promotes nuclear localization of SLBP and increases histone mRNA abundance and stability.^[@ref80],[@ref81]^ Affinity measurements using nitrocellulose filter binding^[@ref76]^ and kinetic measurements using SPR^[@ref75]^ reveal that dephosphorylation of Thr171/Thr230 increases the on-rate of the more basic SLBP protein by 10-fold and also increases the off-rate by 100-fold, thereby decreasing the overall binding affinity (*K*~d~) for the histone stem-loop by ∼7--11 fold.

The crystal structure of the phosphorylated L-motif (PDB code 4QOZ) shows that Thr171 lies in a long flexible loop between helix-2 and helix-3 (residues Val158-Ser179) on the concave face of the L-motif (Figure [3](#fig3){ref-type="fig"}B) and is shielded away from the RNA. The fold is stabilized by a major hydrophobic core at the junction of the two α-helices (Figure [3](#fig3){ref-type="fig"}B). In the unphosphorylated structure,^[@ref77]^ no electron density is observed for residues Pro159-Gln164; however, this segment is ordered in the structure of the phosphorylated Thr171 SLBP--RNA complex. The phosphate has a depressed p*K*~a~ (\<4.5),^[@ref82]^ exhibits torsional strain in solution,^[@ref82]^ and is involved in a network of hydrogen bonding interactions with Arg163, Tyr151, Lys146, and Arg160 in the crystal structure (Figure [3](#fig3){ref-type="fig"}C). The phosphoryl oxygen also makes a hydrogen bond to a water molecule that, in turn, is coordinated to the Trp190 indole nitrogen. A stabilizing γ-methyl-π interaction is observed between the Thr171 γ-methyl group and the indole ring of Trp190, suggesting why threonine, and not serine, may be conserved at this position in all SLBPs. No global conformational changes are observed in the L-motif and the effects of phosphorylation appear to be localized to secondary structure around the site of phosphoryation. The backbone C^α^ atoms show an r.m.s.d. of 0.2 Å between the unphosphorylated and phosphorylated SLBP L-motif (with the exception of residues 165--169).

The structure reveals how phosphorylation at Thr171 may create a binding epitope for another protein in the RNA processing complex (Figure [3](#fig3){ref-type="fig"}D). Previous mutagenesis studies have shown that when Asp152, Arg153, Ile155, Lys156 in helix-2, and Arg160, His161, Leu162, Gln164, and Pro165 in the disordered loop are mutated together, it abolishes histone pre-mRNA processing *in vitro*.^[@ref83]^ Mutation of Arg160 would remove a stabilizing contact with the phosphoryl oxygens, likely making the loop more flexible. However, the side-chains of Arg153, Lys156 in helix-2 and His161, Leu162, and Gln164 are solvent exposed (Figure [3](#fig3){ref-type="fig"}D), lie on the same face, and are ordered in the SLBP--RNA complex in response to phosphorylation. The likely role of Thr171 phosphorylation is to orient these five residues so their side-chains are in a binding competent mode for interaction with an unidentified RNA processing factor.

Therefore, constitutive phosphorylation at Thr171 in the SLBP L-motif is an important "hub" for regulation of the SLBP--histone mRNA complex. The phosphate forms a network of hydrogen-bonding interactions that structures the Pro159-Gln164 loop that is the likely binding site for another protein in the RNA processing complex. At the end of S-phase, Pin1 and PP2A act in concert to dephosphorylate SLBP at Thr171. This would make the loop disordered, likely destabilizing protein--protein interactions in the RNA processing complex. Dephosphorylation at this site facilitates dissociation of the L-motif from the RNA, thereby facilitating histone mRNA degradation.

Besides Thr171, human and *Drosophila* SLBP proteins^[@ref80],[@ref84]^ are also phosphorylated at 3--4 Ser/Thr residues in an acidic region that lies C-terminal to the L-motif (Figure [3](#fig3){ref-type="fig"}A). The functional consequence/s of phosphorylating human SLBP at Ser221, Ser222, and Thr226 in the acidic C-terminal region is currently unknown, although these sites are phosphorylated *in vivo* by mass spectrometry.^[@ref80]^ Inhibition of Pin1 by PiB in HEK cells *in vivo* enriched phosphates at these sites in human SLBP by mass spectrometry, indicating that phosphorylation at these sites may be regulated.^[@ref80]^ In *Drosophila* SLBP, phosphorylation of the C-terminal tail at four serines is required for RNA processing *in vivo*, likely via association with an unknown processing factor.^[@ref84]^ Phosphorylation of the *Drosophila* SLBP C-terminal tail increases binding affinity for histone mRNA stem-loop ∼27-fold by Surface Plasmon Resonance (SPR),^[@ref75]^ although the mechanism for increased affinity is not clear. No structures of SLBP proteins that are phosphorylated at the C-terminus are currently available. Conformational stability measurements using circular dichroism show that C-terminal phosphorylation of dSLBP forms a more stable SLBP--RNA complex,^[@ref73]^ and the effect of phosphorylation is not on the on-rate but on the off-rate of histone mRNA binding.^[@ref75]^ One interpretation of this data is that the phosphorylated C-terminus may interact transiently and nonspecifically with the L-motif in the RNA-bound complex, thereby stabilizing the SLBP--RNA complex. Regardless of the smaller effects of phosphorylation on histone mRNA binding (summarized in Table [1](#tbl1){ref-type="other"}), phosphorylation at these sites is likely to be more important for recruitment of another protein in the histone pre-mRNA processing complex.

Phosphorylated RNA Decay Factors that Bind 14--3--3 and 14--3--3-like Domains {#sec1.6}
=============================================================================

14--3--3 proteins are a family of dimeric, all α-helical domains that bind phosphorylated Ser/Thr residues in eukaryotes.^[@ref85]^ Two optimal binding motifs recognized by 14--3--3 proteins have been identified: Arg--Ser--Xaa--\[pSer/pThr\]--Xaa--Pro or Arg--Xaa--Xaa--Xaa--\[pSer/pThr\]--Xaa--Pro where Xaa denotes any amino acid. Several phosphorylated RNA decay factors interact with 14--3--3 isoforms or with proteins that have 14--3--3-like domains. K-homology splicing regulator protein **(**KSRP) is an mRNA decay promoting factor that binds AU-rich elements (ARE) in the 3′ UTRs of a number of cytokine mRNAs that play important roles in the immune response, initiating ARE-mediated decay (AMD) of these mRNAs.^[@ref86],[@ref87]^ Phosphorylation of KSRP at a serine residue (Ser193) in its N-terminal RNA binding domain (KH1) impairs its ability to recruit the exosome and trigger AMD^[@ref88]^ (Figure [4](#fig4){ref-type="fig"}A). Phosphorylation at Ser193 makes KSRP a substrate for 14--3--3ζ and the phosphorylated KSRP-14--3--3ζ complex translocates from the cytoplasm to the nucleus, thereby decreasing its ability to participate in mRNA decay.^[@ref89]^ The solution NMR structure of KH1 (PDB code 2OPU) shows a typical KH α/β fold with three α-helices packed against a three-stranded antiparallel β-sheet^[@ref89]^ (Figure [4](#fig4){ref-type="fig"}B). Ser193 lies in a structured part of the β-sheet and unphosphorylated KSRP is not capable of associating with 14--3--3ζ (Figure [4](#fig4){ref-type="fig"}B). Intriguingly, phosphorylation at Ser193 destabilizes and unfolds the KH1 domain as determined by NMR spectroscopy and circular dichroism (CD).^[@ref89]^ This order-to-disorder transition is reversible, and dephosphorylation of KH1 at Ser193 results in refolding of the KH domain. Unfolding of KH1 creates a binding site for 14--3--3ζ, which is capable of recognizing the phosphoserine in an extended conformation (Figure [4](#fig4){ref-type="fig"}C). Consistent with this, a 15-residue peptide comprising the KSRP sequence around Ser193 (residues Gly186-Ser200) can effectively compete with KSRP for 14--3--3ζ. The peptide segment Gly186-Ser200 can therefore be considered as the KSRP SRS, which forms a β-strand in the unphosphorylated KH domain. Unfolding of KH1 does not impair the ability of KSRP to bind the mRNA, since the KH3 and KH4 domains of KSRP mediate high affinity RNA binding to the ARE in TNF-α.^[@ref90]^ The role of the SRS in the KH1 domain appears to be to induce a phosphorylation-dependent order-to-disorder switch in KSRP so as to change its subcellular localization via interaction with 14--3--3ζ.

![Structures of phosphorylated mRNA decay factors that bind 14--3--3 or 14--3--3-like domains. (A) Schematic showing domain organization of KSRP. The four KH domains are shown in red and the nuclear localization signals are in blue. (B) Solution NMR structure of the first KH domain (PDB code 2OPU) of KSRP when unphosphorylated. The site of phosphorylation, Ser193, is shown in stick. (C) Comparison of the folding topologies of 14--3--3ζ with 14--3--3-like domains from SMG6, SMG7, and the SMG5-SMG7 complex is shown in purple. The phosphoserine binding site is indicated. (D) Interaction of a phosphoserine peptide with 14--3--3ζ as seen in the crystal structure of the cocomplex (PDB code 1QJB) is depicted. The phosphoserine binds in an extended conformation to 14--3--3 proteins.](cb-2014-00860x_0002){#fig4}

The zinc finger protein Tristetraprolin (TTP) is a well characterized ARE binding protein and is phosphorylated by the kinase MK2 at two serines (Ser60 and Ser186), and is also recognized by 14--3--3. Phosphorylation of TTP by MK2 has no effect on the binding affinity of TTP for the TNF-α ARE in EMSA assays, but promotes its interaction with 14--3--3 proteins thereby altering its subcellular distribution and inhibiting its mRNA decay activity.^[@ref91]^ However, in contrast to KSRP, the TTP SRS that binds 14--3--3 is located in an unfolded region of the protein. No structural information is currently available for phosphorylated TTP, either free or bound to 14--3--3.

Upf1 (also known as RENT1 or SMG-2) is a nonsense-mediated decay (NMD) factor that is an ATP-dependent 5′ to 3′ RNA helicase and the main effector of NMD.^[@ref92],[@ref93]^ NMD is a surveillance mechanism in eukaryotes and a mechanism to detect and degrade mRNA transcripts that have a premature termination codon (PTC). Several crystal structures are available for human Upf1 helicase region (residues 295--914),^[@ref94]^ Upf1 (residues 115--914) bound to the C-terminal region of Upf2 (residues 1105--1198),^[@ref95]^ crystal structures of Upf1--RNA and Upf1--Upf2--RNA complexes,^[@ref96]^ a cryo-EM structure of Upf1 bound to the exon junction complex (EJC)^[@ref97]^ and EM images of SMG1--Upf1 complexes.^[@ref98]^ The overall structure of the helicase core of Upf1 consists of two RecA-like domains that are found in SF1 and SF2 superfamily of helicases. In addition, Upf1 has a N-terminal cysteine-histidine-rich (CH) domain (residues 115--275) that binds Upf2, and a helical domain (residues 556--609). These structures reveal how Upf1 binds RNA and Upf2, providing mechanistic insight into the role of Upf1 in NMD. Upf1 is phosphorylated by the kinase SMG-1^[@ref99],[@ref100]^ (SMG stands for suppressors of morphogenetic defects in genitalia) at Thr28, Ser1078, Ser1096, and Ser1116 SQ motifs *in vivo* in the unstructured N- and C-terminus.^[@ref101],[@ref102]^ Phosphorylation--dephosphorylation cycles at these SQ motifs are essential for NMD. Phosphorylated Upf1 is also important for histone mRNA decay via direct association with SLBP.^[@ref71]^ Phosphorylation of Upf1 at Thr28 in the N-terminus creates a binding site for SMG-6, a monomeric 14--3--3-like protein that has endonucleolytic activity and also binds the exon--exon junction complex or EJC.^[@ref103]^ The C-terminal SQ motifs, in particular, Ser1096 and Ser1116, bind SMG-7 and SMG-5, respectively. SMG-5 and SMG-7 form a stable 14--3--3-like heterodimer (Figure [4](#fig4){ref-type="fig"}C) that binds the C-terminal phosphoserines and catalyzes Upf1 dephosphorylation by recruiting the protein phosphatase PP2A.^[@ref104]^ The crystal structures of SMG-5-SMG7,^[@ref104]^ SMG-6,^[@ref103]^ and truncated SMG-7^[@ref105]^ reveal 14--3--3-like domains that have adjacent helical hairpin domains (Figure [4](#fig4){ref-type="fig"}C). Collectively, the entire unit is referred to as the tetratricopeptide (TPR) region. The phosphoserine binding pockets of the SMG-5, SMG-6, and SMG-7 TPR domain is very similar to that of 14--3--3, indicating a similar mode of interaction with an extended phosphopeptide. The canonical mode of interaction of extended phosphoserine containing peptides by 14--3--3 consists of interaction of the phosphate with two arginines, a tyrosine, and a lysine residue in 14--3--3 (Figure [4](#fig4){ref-type="fig"}D). This mode of interaction appears to be conserved in 14--3--3-like proteins such as SMG-5, SMG-6, and SMG-7. The effect of Upf1 hyperphosphorylation on RNA association has not been quantified. The interaction of the truncated 14--3--3 domain of SMG7 (residues 1--497) with a 12 residue Upf1 phosphopeptide corresponding to the region around Ser1078 has been quantified by isothermal titration calorimetry (ITC) and was found to be 50 μM.^[@ref105]^ The Upf1 phosphopeptide bound SMG7 with a 1:1 stoichiometry. No detectable binding was observed with the unphosphorylated peptide and given the lower limit of detection by ITC, this corresponds to a \>100-fold increase in affinity for SMG7 due to Upf1 phosphorylation. GST pull-down experiments show that the SMG5-SMG7 heterodimer interacts with Ser1096 and Ser1116 of Upf1 in a phosphorylation-dependent manner.^[@ref103]^ No structural information is available on the interaction of Upf1 phosphopeptides with SMG5, SMG6, or SMG7. An important question that remains unanswered is how phosphorylated SQ motifs bind their respective 14--3--3-like domains in a specific manner. For example, the SMG5--SMG7 complex binds phosphorylated Ser1096, but does not bind phosphorylated Thr28.^[@ref102]^ Conversely, SMG-6 binds the sequence around phosphorylated Thr28 but will not bind the region around phosphorylated Ser1096 on Upf1. Future structural studies on the respective complexes should clarify the mode of specific interaction of phosphorylated SQ motifs of Upf1 with SMG proteins in detail.

Other Phosphorylated Proteins Involved in RNA-Mediated Gene Expression {#sec1.7}
======================================================================

There are several proteins in eukaryotes and prokaryotes that are involved in RNA-mediated gene expression and are also regulated by phosphorylation. However, structural and kinetic information is available for only a few other proteins, either in the phosphorylated or nonphosphorylated state. The eukaryotic initiation factor 4E (eIF4E) binds the 7-methylguanine (m7G) cap to regulate cap-dependent translation initiation.^[@ref106]^ A family of 4E binding proteins (4E-BPs) regulates translation in eukaryotes by directly associating with eIF4E in their unphosphorylated states, thereby inhibiting translation.^[@ref107],[@ref108]^ 4E-BPs are phosphorylated at four sites (Thr37, Thr46, Ser65, and Thr70) by the mammalian target of rapamycin (mTOR), resulting in dissociation of phosphorylated 4E-BP from eIF4E.^[@ref109]^ Although 4E-BPs do not bind RNA, multisite phosphorylation of these proteins controls protein--protein interactions at the m7G cap on the 5′ end of the mRNA and hence regulates translation initiation. NMR characterization of full-length unphosphorylated 4E-BP2^[@ref110]^ shows that almost the entire protein is intrinsically disordered with transient helical structure.^[@ref110]^ Interaction with eIF4E occurs via a bipartite interface that is stabilized to form a helix in the ^54^YXXXXL motif upon association with eIF4E.^[@ref110]^ All four phosphorylation sites lie in proximity to the interaction surface with eIF4E. Recent NMR studies^[@ref201]^ show that phosphorylation at Thr37 and Thr46 introduces a dramatic conformational change in 4E-BP2, folding residues Pro18-Arg62 into a four-stranded β-domain that buries the ^54^YXXXXL motif into a β-strand, thereby abrogating interaction with eIF4E.^[@ref201]^ This is a fascinating example of a disorder-to-order transition of an intrinsically disordered protein that weakens binding toward eIF4E by ∼4000 fold.

The only known example in prokaryotes of a phosphorylated RNA binding protein for which crystallographic information (PDB codes 3AMT, 3AMU, 3AU7) is available is tRNA^Ile^-agm^2^C synthetase (TiaS).^[@ref111],[@ref112]^ TiaS is an enzyme that modifies the cytidine (C34) in the wobble position of tRNA^Ile2^ to 2-agmatinylcytidine or Agm^2^C. This base modification is required for AUA codon decoding by tRNA^Ile2^. TiaS catalyzes Agm^2^C formation in an ATP-dependent manner. A 2.9 Å crystal structure of a ternary complex of TiaS bound to ATP and tRNA^Ile2^ reveals the mechanism of base modification by this enzyme.^[@ref112]^ Intriguingly, Thr18 in the active site of TiaS is phosphorylated in the crystal structure and phosphorylation at this site is essential for Agm^2^C formation. Mutation of Thr18 to alanine abrogates enzyme activity. The role of Thr18 appears to be to coordinate Mg^2+^ ions that are important for ATP hydrolysis, but phosphorylation at this site does not promote a conformational change in the protein. This is the only known example of "silent" phosphorylation, that is, where phosphorylation of a Thr in the active site of an RNA binding protein does not result in a conformational change. However, in this case, phosphorylation appears to be part of the catalytic mechanism and does not play an allosteric role in modulating protein--RNA recognition.

An interesting example is Ire1, a transmembrane protein kinase and RNase that is important for triggering the unfolded protein response (UPR).^[@ref113],[@ref114]^ Ire1 is a sensor kinase that activates the UPR signal from the lumen of the endoplasmic reticulum (ER) to the cytosol. Ire1 consists of an N-terminal luminal domain, a transmembrane region, followed by a cytosolic portion that consists of the N- and C-terminal kinase domains, which is followed by the RNase domain that is similar to RNase L. The inactive, unphosphorylated Ire1 is a monomer and is bound to the Hsp70 chaperone Bip.^[@ref115]^ Activation of UPR results in dissociation of Bip and dimerization of the cytosolic kinase domains.^[@ref116],[@ref117]^ Dimerization results in *trans*-autophosphorylation of the activation segment at Ser724 *in vivo*, although phosphorylation has also been observed on Ser726 and Ser729 *in vitro*.^[@ref118]^ Phosphorylation at Ser724 results in a global rearrangement of the kinase and RNase domains that switch from a dephosphorylated and inactive face-to-face conformation to a phosphorylated and active back-to-back conformation.^[@ref119]^ This reorientation of the domains activates RNase endoribonuclease/splicing activity toward Xbp1 mRNA, likely via propagating conformational changes to the RNase domain active site. While a ∼3--5 fold decrease in *K*~m~ for the RNA substrate is observed due to phosphorylation at 1--4 sites, a 2--40 fold effect on *K*~cat~*/K*~m~ is observed.^[@ref118]^ The RNase activity of Ire1 is specific for Xbp1 mRNA and is not spliceosome associated.^[@ref120]^

Although both TiaS and Ire1 are interesting variations in their structural mechanisms, they are both enzymes and not known to be associated with larger ribonucleoprotein complexes.

Concluding Remarks {#sec2}
==================

Currently, 662 structures of proteins that are phosphorylated at serine residues, and 558 structures of proteins phosphorylated at threonine residues have been deposited in the protein data bank (PDB). Phosphorylated RNA binding proteins are a very small subset of these structures and mainly correspond to the proteins discussed in this review. How do the structural mechanisms for control of RNA-binding protein function by phosphorylation discussed here compare to mechanisms observed for other proteins involved in signaling or DNA-binding? Glycogen phosphorylase was the first protein to be studied in both the phosphorylated and nonphosphorylated states,^[@ref121],[@ref122]^ and the structures revealed global conformational changes occur in the protein upon phosphorylation at Ser-14 and Thr-10 leading to allosteric activation. In contrast, phosphorylation of isocitrate dehydrogenase^[@ref123]^ revealed silent effects and no structural change in response to phosphorylation of the active site at Ser113. Several kinase structures are now available in phosphorylated and nonphosphorylated states. Most kinases^[@ref5]^ require phosphorylation of a disordered activation segment to trigger conformational changes in the active site, opening up the bilobed kinase structure, allowing access to the substrate. There are several examples of disorder-to-order or order-to-disorder transitions. Therefore, all the mechanisms discussed in the introduction have been observed for phosphorylated proteins.

In contrast, RNA binding proteins discussed here reveal interesting similarities in the mechanisms by which phosphorylation propagates the signal response at the atomic level (Table [1](#tbl1){ref-type="other"}). First, with the exception of the kinase/RNase Ire1, no global conformational changes have been observed in RNA binding proteins that function as part of ribonucleoprotein (RNP) complexes. The structural and dynamic effects of phosphorylating RNA-binding proteins that are components of RNP complexes are localized in space around the phosphate. Second, phosphorylation usually occurs in a disordered region of the RNA binding domain or the SRS and stabilizes this region. Although the RS domain is highly disordered when unphosphorylated and remains flexible in the phosphorylated state, and there is evidence for formation of a transiently populated structure upon phosphorylation. The KH domain is the only report where phosphorylation occurs in a structured β-strand, which unfolds upon phosphorylation. In all cases, phosphorylation creates a binding site or "hub" for protein--protein interactions. Intriguingly, the effects of phosphorylation on association with the RNA tend to be small and range from either no change to ∼10--30-fold altered binding affinity (*K*~d~).

Phosphorylation of RNA binding proteins also plays regulatory roles in several other RNA-mediated processes such as translation, pre-mRNA processing, and mRNA export. It is anticipated that future structural studies may reveal additional mechanisms by which ribonucleoprotein complexes are controlled by phosphorylation-dependent signaling.
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**Phosphorylation**

:   Addition of a phosphate group to a protein to alter protein function

**RNA-binding protein**

:   A protein macromolecule that associates directly and noncovalently with RNA to regulate gene expression

**Serine/arginine-rich Splicing Factor 1 (SFRS1)**

:   A protein that is a component of the spliceosome to regulate alternative splicing

**Splicing Factor 1 (SF1)**

:   A protein that is involved in formation of the E complex of the spliceosome

**Stem-loop binding protein (SLBP)**

:   A protein that binds histone mRNA stem-loop to regulate histone mRNA processing, export, translation, and decay

**K-homology splicing regulator protein (KSRP)**

:   An RNA-binding protein that regulates the translation and stability of a subset of mRNAs that contain AU-rich elements (ARE)

**ATP-dependent RNA helicase upframeshift 1 (Upf1)**

:   A protein that is part of the exon junction complex, that regulates degradation of nonsense mRNA transcripts

**14--3--3 proteins**

:   A family of conserved proteins in eukaryotes that bind other phosphorylated proteins to regulate signaling and mRNA transport processes in the cell

**pre-mRNA splicing**

:   A biological process by which exons from primary mRNAs are joined together, with excision of introns, to produce a mature mRNA transcript

**mRNA decay**

:   A biological process that regulates the stability of mRNAs by facilitating their degradation

**histone mRNA**

:   Non-polyadenylated and cell-cycle regulated mRNAs that encode for histone proteins during S-phase. Histone proteins are required to package DNA into chromatin

**RNA--protein interaction**

:   interaction between RNA and protein to regulate gene expression
